Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1, 2-diarylimidazoles are potent, orally active antiinflammatory agents

IK Khanna, Y Yu, RM Huff, RM Weier, X Xu…

Index: Journal of Medicinal Chemistry, , vol. 43, # 16 p. 3168 - 3185

Full Text: HTML

Citation Number: 105

Abstract

... Journal of Medicinal ... Discovery Medicinal Chemistry and Inflammatory Disease Research, Pharmacia Corporation, 4901 Searle Parkway, Skokie, Illinois 60077. J ... 3185. DOI: 10.1021/jm0000719. Publication Date (Web): July 21, 2000. Copyright © 2000 American Chemical ...

Related Articles:

Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism

[French, Jarrod B.; Cen, Yana; Vrablik, Tracy L.; Xu, Ping; Allen, Eleanor; Hanna-Rose, Wendy; Sauve, Anthony A. Biochemistry, 2010 , vol. 49, # 49 p. 10421 - 10439]

Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism

[Biochemistry, , vol. 49, # 49 p. 10421 - 10439]

Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism

[Biochemistry, , vol. 49, # 49 p. 10421 - 10439]

More Articles...